From strategic innovation in clinical development and the evolving regulatory landscape to the voice of patients and the promise of new technologies, the healthcare sector is undergoing a period of significant change. And nowhere is this more visible than in the world of clinical research.
"We need to keep Belgium attractive for conducting clinical trials by being agile and open for improvements in our network and procedures. This is an effort that should be taken by all stakeholders and will result in a favourable climate."
Nele Steens, Head of R&D at Belgium’s Federal Agency for Medicines and Health Products (FAMHP)During the recent Healixia clinical conference on clinical research hosted by PwC Belgium, Nele Steens, Head of R&D at Belgium’s Federal Agency for Medicines and Health Products (FAMHP), and Simon Hall, Life Sciences R&D Director at PwC Switzerland, shared their vision for tomorrow’s health.
Discover more in our insightful interview.
Discover more in our insightful interview
The role of clinical trials in our health ecosystem
Contact us
